U.S. Multiple Sclerosis Markets

Table of Contents

Executive Summary

• Introduction

Introduction

• Multiple Sclerosis
• Scope and Segmentation
• Research Methodology

Disease Overview

• Causes of Multiple Sclerosis
• Classification of Multiple Sclerosis
• Treatment Options

Market Overview

• Market Engineering Measurements
• Market Trends

Product Analysis

• Interferons
• Copaxone
• Tysabri
• Novantrone
• Pipeline Drugs

Patient Forecasts

• Total Patient Forecasts
• Patient Forecast by Product

Revenue Forecasts

• Total Market Revenue Forecasts
• Revenue Forecasts by Product

Competitive Analysis

• Competitive Structure
• Company Market Share

Competitve Metrics

• Methodology and Metrics
• Biogen Idec
• Teva Pharmaceuticals
• EMD Serono
• Bayer Schering Pharma
• Emerging Companies

Demographic Indicators

• Total Population

Market Indicators

• World Multiple Sclerosis Prevalence
• U.S. Multiple Sclerosis Prevalence
• U.S. Multiple Sclerosis Incidence
• Pharmaceutical R&D Expenditure